N/A
Completed N=189
Physical Therapy and Occupational Therapy After Transcatheter Aortic Valve Replacement
Transcatheter Aortic Valve Implantation
Source: ClinicalTrials.gov NCT03117296 ↗
Enrolled (actual)
189
Serious AEs
—
Results posted
Jan 2023
Primary outcomePrimary: Post Procedure Hospital Length of Stay — 4.8; 3.5 days
Summary
Implementation of Physical Therapy (PT) and Occupational Therapy (OT) pathway (initiation of services on Post procedure day #1 and continued daily with focus on education and activity progression) for all patients undergoing a transcatheter aortic value repair procedure began on December 2, 2014. Retrospective data was collected from The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Aortic Valve Replacement Procedures (STS/ACC TVT, trademark) Registry - National database for Transcatherter Aortic Valve Replacement Procedures and included subjects from March 2012 through July 31, 2015. Patients included: s/p tAVR via transfemoral catheter approach, with or without minor intra or post procedure events (GI bleeds, minor access bleeds, afib, etc); Exclusions: Major events including stroke, pacemaker placement, other cardiovascular (CV) repair or surgery required, etc). Future data analysis will extend subjects to December 31, 2015 and annually.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Post Procedure Hospital Length of Stay |
4.8; 3.5 | — |
| PRIMARY Total Hospital Length of Stay |
6.9; 4.5 | <0.01 sig |
| SECONDARY Discharge Disposition, Home |
57; 99 | — |
| SECONDARY Discharge Destination, Rehab Facility |
17; 16 | — |
Eligibility Criteria
Inclusion Criteria
- admission to henry ford hospital after March 1, 2012
- status post transcatheter aortic valve replacement via transfemoral catheter approach, with or without minor intra or post procedure events (GI bleeds, minor access bleeds, afib, etc)
Exclusion Criteria
- Occurrence of major events including stroke, pacemaker placement, other CV repair or surgery required, etc)
- procedure via appropriate other than femoral access (transapical, transcaval)
Data sourced from ClinicalTrials.gov (NCT03117296). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.